98%
921
2 minutes
20
Introduction: Robotic-assisted kidney autotransplantation (RAKAT) is a minimally invasive approach to managing complex renal pathologies. While increasingly utilized, experience with RAKAT in patients with prior renal surgery remains limited.
Methods: We present a case of recurrent nutcracker syndrome (NCS) in a 29-year-old female who had previously undergone left renal vein transposition. Due to recurrent symptoms, she underwent RAKAT with extracorporeal vascular reconstruction using cryopreserved allografts to manage the foreshortened renal vessels. The surgical technique involved a multiport robotic approach with a hand-assist device, extracorporeal bench surgery, and repositioning for the autotransplantation phase.
Results: The procedure was completed successfully with a total operative time of 779 minutes and estimated blood loss was 100 mL. The cold ischemic time was 90 minutes. Postoperative complications included urinary tract infections requiring intravenous antibiotics (Clavien-Dindo grade II). At 7 months follow-up, the patient had excellent graft function and no evidence of recurrent NCS.
Conclusion: This case demonstrates the feasibility of RAKAT with extracorporeal vascular reconstruction using allografts as a salvage therapy for recurrent NCS after prior open surgery. This approach requires advanced robotic and vascular expertise and careful preoperative planning.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SLE.0000000000001400 | DOI Listing |
J Robot Surg
September 2025
Department of Urology/School of Clinical Medicine, North Sichuan Medical College/Affiliated Hospital of North Sichuan Medical College, No. 1, South Maoyuan Road, Shunqing District, Nanchong City, 63700, Sichuan Province, China.
Renal transplantation is the best option for end-stage renal disease, and in this study, patients who underwent robotic-assisted renal transplantation (RAKT) and open renal transplantation (OKT) were selected to compare their intraoperative and postoperative clinical outcomes: including Operation Time, Length of Stay, WIT (warm ischaemia time), CIT (cold ischaemia time), Estimated Blood Loss, Post 1 month Creatinine, Incision Length, Rewarming Time, Wound infection. The study was registered in PROSPERO with CRD code: CRD420251061084. We searched in Web of Science, Pubmed, Wiely, Elsevier databases, screened according to inclusion and exclusion criteria and finally included 7 papers.
View Article and Find Full Text PDFWorld J Urol
September 2025
Department of Urology, Taipei Veterans General Hospital, No. 201, Section 2, Shipai Road, Taipei, 11217, Taiwan.
Purpose: To determine the incidence of renal artery pseudoaneurysm (RAP) after robotic-assisted partial nephrectomy (RaPN), identify predictive factors, and evaluate endovascular management.
Methods: The institutional RaPN database was retrospectively reviewed, and data from December 2009 to June 2021 were used. Computed tomography angiography was used to diagnose RAP.
J Robot Surg
September 2025
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The aim of our study is to compare and assess the correlation of preoperative factors, intraoperative events and post-operative outcomes of robot assisted transperitoneal (RATP) and robot assisted retroperitoneal (RARP) partial nephrectomy (PN) in T1 renal cancer. Data from 2609 patients during the period of 10 years who underwent either RATP or RARP partial nephrectomies was retrospectively analyzed. We compared preoperative factors (age, BMI, tumour size/stage, PADUA score, preoperative eGFR, history of previous abdominal and ipsilateral surgery), intraoperative events: operative time (OT), warm ischemia time (WIT), estimated blood loss (EBL), and post-operative outcomes: complications, eGFR, positive surgical margins (PSM), and death due to disease (DOD) or due to other causes (DOC) and survival rates.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Urology, Harbin Medical University Cancer Hospital, Harbin, China.
This study aimed to compare the safety and efficacy of robot-assisted partial nephrectomy with the two Chinese Robotic systems versus the da Vinci Xi Surgical System. This prospective analytical study included 170 patients who underwent robotic-assisted partial nephrectomy between February 2023 to June 2024. The study included 85 patients who received treatment using two Chinese robotic systems (KangDuo SR 2000: KD-SR-2, EDGE MP1000) and 85 who underwent the da Vinci (DV) surgical system during the same period.
View Article and Find Full Text PDFCancers (Basel)
August 2025
Department of Urology, Humanitas Gavazzeni, 24125 Bergamo, Italy.
Objective: To evaluate the perioperative outcomes, functional impact, and oncologic efficacy of off-clamp robotic-assisted partial nephrectomy (RAPN) in patients with renal masses across multiple high-volume centers.
Materials And Methods: We conducted a retrospective multicenter study including 563 patients (group 1) who underwent clampless RAPN between January 2018 and December 2024. Patients with solitary kidneys, tumors >7 cm, or prior renal surgery were excluded.